Your session is about to expire
← Back to Search
Prebiotic Fiber
Prebiotic for Epilepsy (EPBiome Trial)
Phase 4
Waitlist Available
Research Sponsored by British Columbia Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 2-18.
Attended the epilepsy clinic for a minimum of 6 months.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
EPBiome Trial Summary
Role of the Gut Microbiota in Pediatric Epilepsy
Eligible Conditions
- Epilepsy
EPBiome Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowEPBiome Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Short Chain Fatty Acid (SCFA) levels in stool
Change in alpha and beta bacterial diversity measures in stool
Secondary outcome measures
Seizure frequency
EPBiome Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: PrebioticExperimental Treatment1 Intervention
Oligofructose-enriched inulin 4 grams daily for ≤ age 6; or 8 grams daily for >6 years
Group II: PlaceboPlacebo Group1 Intervention
Maltodextrin 4 grams daily for ≤ age 6; or 8 grams daily for >6 years
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prebiotic
2016
Completed Phase 2
~720
Find a Location
Who is running the clinical trial?
British Columbia Children's HospitalLead Sponsor
25 Previous Clinical Trials
15,186 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger